454
A.Z. El-Sonbati et al. / Journal of Molecular Liquids 218 (2016) 434–456
DNA was added to both the compound solution and the reference so-
lution to eliminate the absorbance of DNA itself. We have deter-
mined the intrinsic binding constant to CT-DNA by monitoring the
absorption intensity of the charge transfer spectral bands 345, 351,
321, 348, 341 nm for the ligand and Cu(III), Co(II), Ni(II) and Cd(II)
complexes, respectively. The absorption spectra of these ligand and
complexes (1–4) with increasing concentration of CT-DNA in the
range 300–700 nm are shown in Fig. 16.
DNA interaction study by UV–Visible Spectroscopy Electronic ab-
sorption spectra were initially used to examine the interaction be-
tween ligand and CT-DNA. After interaction with increasing
amount of DNA, the absorption spectra of ligand and its metal com-
plexes (1–4) display clear hypochromism with slight blue shift
(~1–2 nm). After the intercalation of the compounds into the base
pairs of DNA, the π* orbital of the intercalated compounds are able
to couple with the π orbitals of the base pairs, thereby decreasing
the π → π* transition energies. These interactions result in the ob-
served hypochromism [68].
tested to increase the chance of detection of their antimicrobial activi-
ties. The used organisms in the present investigations included Gram
positive (S. aureus), Gram negative (E. coli) bacteria and yeast
(C. albicans). The results of the antimicrobial activities of the synthe-
sized compounds were recorded in Table 12. The zone of inhibition
was measured in mm and was compared with a standard drug. DMSO
was used as a blank and ampicillin was used as the antibacterial stan-
dard and colitrimazole was used as the yeast standard. The results indi-
cate that, these compounds are active in inhibiting the growth of the
bacterial and fungal species [70]. All the compounds were tested at
1 mg/mL concentration. The data show that the ligand is the most active
than complexes against E. coli, with % activity index 41.7. The ligand and
Cd(II) complex display good inhibitory properties against the tested
S. aureus and C. albicans with % activity index 63.6 and 72.7 for
S. aureus and 96.1 and 80.8 for C. albicans, respectively.
3.12. Antioxidant assay
The intrinsic binding constant (Kb) of ligand and its metal complexes
(1–4) with DNA was obtained by observing the changes in absorbance
of the complexes with increasing concentration of DNA. Kb values for li-
gand and Cu(II), Co(II), Ni(II) and Cd(II) complexes were found to be
In vitro antioxidant activities of all the synthesized compounds
were evaluated by 2,2-azinobis-3-ethylbenzothiazoline-6-sulfonic
acid (ABTS) cation radical assay as stable free radical which is a con-
ventional and excellent model for assessing the antioxidant activities
of hydrogen donating and chain breaking antioxidants [71]. Radical
scavenging ability and percentage of inhibition (%) expressed as:
2.99 × 106, 1.34 × 105, 1.19 × 105, 1.10 × 105 and 1.26 × 105 M−1
respectively.
,
AðcontrolÞ−AðtestÞ
3.10. Structural interpretation
% Inhibition ¼
ꢃ
100
AðcontrolÞ
The structures of the complexes of Schiff base HL, with Cu(II), Co(II),
Ni(II) and Cd(II) ions are confirmed by elemental analysis, molar con-
ductivity, 1H NMR, UV–vis, IR, mass spectroscopy, X-ray, magnetic mea-
surements and thermal analysis data. Therefore, from the IR spectra, it is
concluded that HL behaves as a neutral bidentate ligand with NO sites
and coordinated to the metal ions via the azomethine N and carbonyl
O. From the molar conductance data of the complexes, it is concluded
that the complexes are considered as non-electrolytes. The 1H NMR
spectra of the free ligand and its diamagnetic Cd(II) complex shows
that the azomethine signal participate in chelation, without proton NH
and OH signals of HL and complex displacement and/or coordinated.
On the basis of the above observations and from the magnetic and spec-
tral measurements, octahedral geometry is suggested for the investigat-
ed complexes are shown in Fig. 1.
The results of the antioxidant activities of the synthesized com-
pounds were recorded in Table 13. The ligand exhibited a potent radical
scavenging ability with % inhibition value 83.3% which comparable to
that of Ascorbic-acid 89%. Compound having –OH (phenolic) group in
the phenyl ring as in ligand was found to be the most potent antioxi-
dants [72]. On the other hand, Cd(II) and Co(II) complexes showed
moderate antioxidant activity. All complexes of HL represented a
lower antioxidant activity compared to its un-complexed compound.
In accordance with the cytotoxicity testing results, the complexation de-
creases the biological activity of the synthesized compound.
3.13. Cytotoxicity assay
The synthesized compounds ligand and its metal complexes (1–4)
were first evaluated with two cancer cell lines (Hepatocellular carcino-
ma (HepG-2) and mammary gland breast cancer (MCF-7) in vitro by the
standard 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
3.11. Antimicrobial activity
The antibacterial activity of the Schiff bases may arise from the pres-
ence of imine groups and also from the presence of the hydroxyl groups
because of their capacity of hydrogen bonding interactions with cellular
compartment [69].
The antimicrobial activity of (HL) and metal complexes (1–4) were
tested against bacteria and yeast. More than one test organism was
Table 14
Evaluation of cytotoxicity of Ligand (HL) and their metal complexes (1–4) against HepG-2
and MCF-7 cells.
Cell lines
HepG-2
Sample conc.
Compound
5-FU
HL
(1)
43.6
55.8
67.2
79.3
93.6
100
100
100
(2)
38.3
50.4
62.7
75.0
89.6
100
100
100
(3)
33.9
45.8
58.1
68.7
90.3
100
100
100
(4)
20.8
27.3
38.1
51.7
72.6
91.5
100
100
37.9
49.5
61.4
75.8
91.7
100 μg/ml
50 μg/ml
25 μg/ml
12.5 μg/ml
6.25 μg/ml
3.125 μg/ml
1.56 μg/ml
0 μg/ml
100 μg/ml
50 μg/ml
25 μg/ml
12.5 μg/ml
6.25 μg/ml
3.125 μg/ml
1.56 μg/ml
0 μg/ml
8.6
17.1
24.0
33.1
56.8
70.6
88.7
100
16.3
25.1
36.7
48.2
67.5
88.9
100
100
33.3
Table 13
Antioxidant assay for the prepared ligand and its metal complexesa.
Method compounds
ABTS
Abs(control) − Abs(test) / Abs(control) × 100
Absorbance of samples
% inhibition
MCF-7
5.8
45.6
41.3
47.3
Control of ABTS
Ascorbic-acid
0.520
0.057
0.087
0.315
0.281
0.321
0.172
0%
10.3
16.2
28.5
48.4
62.8
81.6
100
46.2
58.4
69.8
90.5
100
100
100
57.3
71.4
82.5
97.1
100
100
100
52.7
64.1
77.5
91.3
100
100
100
58.5
71.7
82.9
96.8
100
100
100
89.0%
83.3%
39.4%
46.0%
38.3%
66.9%
(HL)
(1)
(2)
(3)
(4)
100
100
100
a
Numbers given in Table 2.